Transforming Large B-Cell Lymphoma (LBCL): CAR T and Novel Agents - Episode 8

CAR T: A Review of Clinical Data for Second Line Treatments of Large B-Cell Lymphoma

Dr. Locke reviews the latest data from ZUMA-7 and TRANSFORM studies, evaluating CAR T in the second line setting for R/R LBCL.